The first TG Therapeutics trade was made in Q1 2018.
Since then Steven Cohen bought shares five more times and sold shares on six occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in TG Therapeutics anymore.
Avg closing price
Price range
Sold -612 Thousand shares
Q4 2023
Avg closing price
$11.62
Price range
$6.68
-
$18.81
Increased shares by 92.2% (+293 Thousand shares)
Q3 2023
Avg closing price
$13.94
Price range
$8.36
-
$26.50
Increased shares by 1438.9% (+298 Thousand shares)
Q2 2023